Statistics for Polymorphisms associated with adalimumab and infliximab response in moderate to-severe plaque psoriasis

Total visits

views
Polymorphisms associated with adalimumab and infliximab response in moderate to-severe plaque psoriasis 68

Total visits per month

views
June 2024 19
July 2024 7
August 2024 9
September 2024 9
October 2024 6
November 2024 1
December 2024 0

File Visits

views
Polymorphism_Ovejero_et_al_PHAR_2018.pdf 16

Top country views

views
Russia 20
United States 17
Spain 11
United Kingdom 6
China 5
Argentina 1
Australia 1
Mongolia 1
Singapore 1

Top city views

views
Madrid 11
Noginsk 10
Balashikha 3
Moscow 3
Odintsovo 2
Boardman 1
Melbourne 1
Wuhan 1